Summit Therapeutics has revealed that a second pivotal trial of its Akeso-partnered PD-1xVEGF bispecific ivonescimab has failed to show an improvement in overall survival in a lung cancer trial. New ...

Responsible investment stewardship requires that asset owners and institutional investors understand the long-term ESG risks under the surface of portfolios. The Morningstar Sustainable Investing ...

The Center for Digital Government (CDG) has recognized and benchmarked state and local government’s online progress for over 20 years. CDG is taking this recognition to the next level with the GovX ...

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.

Thank you for reporting this station. We will review the data in question. You are about to report this weather station for bad data. Please select the information that is incorrect.